Cord Blood America Announces CorCell, Highmark Marketing Alliance.LOS ANGELES & PHILADELPHIA -- Cord Blood cord blood n. Blood present in the umbilical vessels at the time of delivery. America, Inc. (OTCBB OTCBB See OTC Bulletin Board (OTCBB). :CBAI CBAI The Community Bankers Association of Illinois CBAI Contract Bridge Association of Ireland (UK) ), the umbilical cord blood umbilical cord blood Transplantation A source of primitive and stem cells that can be used to reconstitute BM destroyed by aplastic anemia or by RT or chemotherapy for CA, lymphoproliferative malignancies. See Bone marrow transplantation, Stem cell therapy. stem cell stem cell In living organisms, an undifferentiated cell that can produce other cells that eventually make up specialized tissues and organs. There are two major types of stem cells, embryonic and adult. preservation company (http://www.cordblood-america.com), focused on bringing the life saving potential of stem cells stem cells, unspecialized human or animal cells that can produce mature specialized body cells and at the same time replicate themselves. Embryonic stem cells are derived from a blastocyst (the blastula typical of placental mammals; see embryo), which is very young to families nationwide and internationally, announced today that CorCell, Philadelphia, Pa., whose operating entity and assets were recently purchased by the Company, has entered into a marketing alliance with Highmark Inc., the largest Pennsylvania health insurer based on membership and one of the largest health insurers in the U.S. "The alliance brings the knowledge and awareness of the significant value of storing umbilical cord blood to Highmark members, providers and employer groups," said Marcia Laleman, CorCell's President. "Highmark selected CorCell as a strategic value added program and CorCell will offer Highmark members a preferred price for the cord blood banking service." CorCell is a national leader in private family cord blood banking. It is the fourth largest private umbilical cord blood bank in the U.S. "Cord blood stem cells cord blood stem cells Umbilical cord blood Hematology A therapeutic 'agent' containing concentrated hematopoietic stem cells for Pts with BM depleted–'wiped out' by disease; they are transfused into HLA-identical siblings and used to reconstitute the BM of may be used today to treat more than 70 diseases including leukemia, severe anemia, metabolic blood disorders and immune deficiencies with many additional uses currently under investigation in clinical trials. Previously the umbilical cord, which contains a rich store of stem cells, had been thrown away at birth," Ms. Laleman said. "We are pleased to work with CorCell to enable our members to take advantage of this service," said Carey Vinson, M.D., Highmark's vice president of Quality and Medical Performance Management. "This program is another way Highmark enables its members to have a greater hand in their health." CorCell offers cord blood banking services directly to Highmark members. Highmark markets the service to its members through educational materials and mailings. "Cord Blood America is delighted to announce this new initiative and is looking forward to the value it will bring to both Highmark members and our shareholders," said Matthew Schissler, CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board. of Cord Blood America, Inc. About Cord Blood America Cord Blood America (OTCBB:CBAI) is the parent company of CorCell, which facilitates umbilical cord blood stem cell preservation for expectant parents and their children. Its mission is to be the most respected stem cell preservation company in the industry. Collected through a safe and non-invasive process, cord blood stem cells offer a powerful and potentially life-saving resource for treating a growing number of ailments, including cancer, leukemia, blood, and immune disorders. To find out more about cord blood banking, visit our website at www.corcell.com. For investor information on Cord Blood America, Inc. (OTC Bulletin Board OTC Bulletin Board An electronic quotation listing of the bid and asked prices of OTC stocks that do not meet the requirements to be listed on the NASDAQ stock-listing system. :CBAI), visit www.cordblood-america.com. About Highmark As one of the leading health insurers in Pennsylvania, Highmark Inc.'s mission is to provide access to affordable, quality health care enabling individuals to live longer, healthier lives. Based in Pittsburgh, Highmark serves 4.6 million people through the company's health care benefits business. Highmark contributes millions of dollars to help keep quality health care programs affordable and to support community-based programs that work to improve people's health. The company provides the resources to give its members a greater hand in their health. Highmark Inc. is an independent licensee of the Blue Cross and Blue Shield Association
Forward-Looking Statements Some statements made in this press release are forward-looking statements, which are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act The Private Securities Litigation Reform Act of 1995 (PSLRA) implemented several significant substantive changes affecting certain cases brought under the federal securities laws, including changes related to pleading, discovery, liability, class representation and awards fees and of 1995. We use words such as "anticipate," "believe," "expect," "future," "intend," "plan," and similar expressions to identify forward-looking statements. These statements including those related to the growth of the industry, new stem cell treatments Medical researchers believe that stem cell treatments have the potential to change the face of human disease and alleviate suffering. A number of stem cell treatments already exist, although most are still experimental and/or costly, with the notable exception of bone marrow , and the Company's performance, are only predictions and are subject to certain risks, uncertainties and assumptions. Additional risks are identified and described in the Company's public filings with the Securities and Exchange Commission. Statements made herein are as of the date of this press release and should not be relied upon as of any subsequent date. The Company's past performance is not necessarily indicative of its future performance. The Company does not undertake, and the Company specifically disclaims any obligation to update any forward-looking statements to reflect occurrences, developments, events, or circumstances after the date of such statement. |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion